Overhaul of U.S. FDA Inspectorate Will Include Dedicated Device Inspectors

International Medical Device Regulatory Monitor
The U.S. Food and Drug Administration last month unveiled a broad plan that will change the way it inspects devicemakers, handles recalls, issues and reviews enforcement decisions and screens imports, with companies likely to start feeling the impact by the end of 2015.

To View This Article: